Dichloroacetate stabilizes the mutant E1α subunit in pyruvate dehydrogenase deficiency

Neurology

Volumn 53, Issue 3, 1999, Pages 612-616

  Morten, K J ^a,c   Beattie, P ^a   Brown, G K ^b   Matthews, P M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DICHLOROACETIC ACID; GENE PRODUCT; MUTANT PROTEIN; PROTEIN SUBUNIT; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVATE DEHYDROGENASE E1ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG MECHANISM; ENCEPHALOMYOPATHY; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; LACTIC ACIDOSIS; NERVE DEGENERATION; PRIORITY JOURNAL; PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY; SEIZURE;

EID: 0033546623     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.3.612     Document Type: Article

References (28)

1. Brown GK. Pyruvate dehydrogenase El alpha deficiency. J Inherit Metab Dis 1992;15:625-633.
2. Robinson B. Lactic acidemia. Biochim Biophys Acta 1993; 1182:231-244.
3. Brown R, Brown GK. X-Chromosome inactivation and the diagnosis of X-linked disease in females. J Med Genet 1993;30: 177-184.
4. De Vivo DC. The expanding clinical spectrum of mitochondrial diseases. Brain Dev 1993;15:1-21.
5. Patel MS, Roche TE. Molecular biology and biochemistry of pyruvate dehydrogenase complexes. FASEB J 1990;4:3224-3233.
6. Dahl HH, Brown GK, Brown RM, et al. Mutations and polymorphisms in the pyruvate dehydrogenase E1 alpha gene. Hum Mutat 1992;1:97-102.
7. Brown RM, Dahl HH, Brown GK. X-Chromosome localization of the functional gene for the EIa subunit of the human pyruvate dehydrogenase complex. Genomics 1989;4:174-181.
8. Morten KJ, Caky M, Matthews PM. Mechanisms of expression of pyruvate dehydrogenase deficiency caused by an E1α subunit mutation. Neurology 1998;51:1324-1330.
9. De Vivo DC. Complexities of the pyruvate dehydrogenase complex. Neurology 1998;51:1247-1249.
10. Matthews PM, Brown RM, Otero L, Marchington D, Leonard JV, Brown GK. Neurodevelopmental abnormalities and lactic acidosis in a girl with a 20 bp deletion in the X-linked pyruvate dehydrogenase El alpha subunit gene. Neurology 1993; 43:2025-2050.
11. Matthews PM, Otero LJ, Marchington D, et al. Pyruvate dehydrogenase deficiency: clinical presentation and molecular genetic characterisation of five new patients. Brain 1994;117: 435-443.
12. Stacpoole PW, Wright EC, Baumgartner TG, et al. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults: the Dichloroacetate Study Group. N Engl J Med 1992;327:1564-1569.
13. De Stephano N, Matthews PM, Ford B, Genge A, Karpati G, Arnold DL. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 1995;45:1193-1198.
14. Kimura S, Oktuki N, Nezu A, Tanaka M, Takehita S, Minami K. Clinical and radiologic improvements in mitochondrial encephalomyelopathy following sodium dichloroacetate therapy. Brain Dev 1997;19:535-540.
15. Toth PP, El-Shanti H, Elvins S, Rhead WJ, Klein JM. Transient improvement of congenital lactic acidosis in a male infant with pyruvate decarboxylase deficiency treated with dichloroacetate. J Pediatr 1993;123:427-430.
16. Whitehouse S, Cooper RH, Randle PJ. Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxilic acids. Biochem J 1974;41:761-774.
17. Morten KJ, Caky M, Matthews PM. Stabilization of the pyruvate dehydrogenase E1α subunit by dichloroacetate. Neurology 1998;51:1331-1335.
18. Hansen LL, Brown GK, Kirby DM, Dahl H-HM. Characterisation of the mutations in three patients with pyruvate dehydrogenase E1α deficiency. J Inherit Metab Dis 1991;14:140-151.
19. Van Essen AJ, Abbs, Baiget M, et al. Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study. Hum Genet 1992;88:249-257.
20. Otero LJ, Brown RM, Brown GK. Arginine 302 mutations in pyruvate dehydrogenase El alpha subunit gene: identification of further patients and in-vitro demonstration of pathogenicity. Hum Mutat 1998;12:114-121.
21. Sailoh S, Morrioi M, Yamagata T, Mori Y. Effects of dichloro-acetate in three patients with MELAS. Neurology 1998;50: 531-534.
22. Cenciarelli C, Wilhelm KG, Guo A, Weissman AM. T cell antigen receptor ubiquitination is a consequence of receptor mediated tyrosine kinase activities. J Biol Chem 1995;271: 8709-8713.
23. Chen Z, Hagler J, Palombella VJ, et al. Signal induced site specific phosphorylation targets I kappa B-alpha to the ubiquitin proteasome pathway. Genes Dev 1995;9:1586-1597.
24. Wickling CA, Scholem RD, Hunt SM, Brown GK. Immunochemical analysis of normal and mutant forms of human pyruvate dehydrogenase. Biochem J 1986;239:89.
25. Old SE, De Vivo DC. Pyruvate dehydrogenase complex deficiency: biochemical and immunoblot analysis of cultured skin fibroblasts. Ann Neurol 1989;26:746.
26. Debburman SK, Raymond GJ, Caughey B, Lunquist S. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci USA 1997;94: 13938-13943.
27. Brown RC, Hong Brown LQ, Welch WJ. Strategies for correcting the delta 508 CFTR protein folding defect. J Bioenerg Biomembr 1997;29:491-502.
28. Shevell M, Matthews PM, Scriver CR, et al. Cerebral dysgenesis and lactic acidemia: an MRI/MRS phenotype associated with pyruvate dehydrogenase deficiency. Pediatr Neurol 1994; 11:224-229.